|
Real-time Estimate
Cboe BZX
10:27:55 24/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 91.50 USD | -0.91% |
|
+3.41% | +38.29% |
| 13/08 | Citigroup Adjusts Price Target on DexCom to $105 From $88, Maintains Buy Rating | MT |
| 04/08 | Argus Adjusts Price Target on DexCom to $96 From $86, Maintains Buy Rating | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
| 94.12 | +1.93% | 25 | |||||||
| 120.2 | +3.05% | 25 | |||||||
| 98.44 | +5.45% | 25 | |||||||
| 369.31 | +16.12% | 13 | |||||||
| 30,620 | +23% | 15 | |||||||
| 194.42 | +1.26% | 12 | |||||||
| 44.62 | +30.23% | 26 | |||||||
| 404.73 | +14.63% | 15 | |||||||
| 3,133.08 | +21.96% | 13 | |||||||
| 263.12 | +10.59% | 8 | |||||||
| 232.64 | +20.23% | 14 | |||||||
| 107.57 | +6.53% | 21 | |||||||
| 42.59 | -2.14% | 11 | |||||||
| 93.92 | +4.86% | 13 | |||||||
| 28.73 | +9.06% | 11 | |||||||
| 103.23 | +18.78% | 13 | |||||||
| 208.6 | +28.33% | 15 | |||||||
| 171.91 | +16.03% | 22 | |||||||
| 185.7 | +2.52% | 20 | |||||||
| 329 | -13.43% | 5 | |||||||
| Average | 1,842.3 | +10.95% | 16 | ||||||
| Weighted average by Cap. | 2,344.87 | +9.13% | 19 |
- Stock Market
- Stocks
- DXCM Stock
- Sector DexCom, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
















